The Oncology Institute, Inc. (STLN) — Cash Flow-to-Debt Ratio
The Oncology Institute, Inc. (STLN) has a Cash Flow-to-Debt Ratio of 0.06x as of June 2026, meaning its operating cash flow of $11.94 Million could theoretically repay 0% of its total liabilities ($203.15 Million) in one year. Check The Oncology Institute, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
The Oncology Institute, Inc. Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for The Oncology Institute, Inc. across 4 annual periods. Check The Oncology Institute, Inc. cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Annual Cash Flow-to-Debt Ratio for The Oncology Institute, Inc. (2022–2025)
Year-by-year debt coverage analysis for The Oncology Institute, Inc.. For the full cash flow conversion analysis, see STLN cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-24.59 Million | $180.38 Million | ▲ +13.1% |
| 2024 | -0.16x | $-26.54 Million | $169.13 Million | ▲ +34.2% |
| 2023 | -0.24x | $-36.31 Million | $152.22 Million | ▲ +46.5% |
| 2022 | -0.45x | $-61.76 Million | $138.49 Million | — |